Gregory S Park1, Kathleen F Ireland1, Robert O Opoka2, Chandy C John3. 1. Department of Pediatrics, University of Minnesota Medical School, Minneapolis. 2. Makerere University Faculty of Medicine, Kampala, Uganda. 3. Department of Pediatrics, University of Minnesota Medical School, Minneapolis ccj@umn.edu.
Abstract
BACKGROUND: Endothelial activation may contribute to development of severe disease from Plasmodium falciparum infection, but optimal markers of endothelial activation in severe malaria, the extent of endothelial activation in asymptomatic infection, and the effect of blood group O on endothelial activation have not been defined. METHODS: Serum levels of 3 markers of endothelial activation-von Willebrand factor (VWF), soluble intercellular adhesion molecule-1 (sICAM-1), and soluble vascular cell adhesion molecule-1 (sVCAM-1)-were assessed in Ugandan children with cerebral malaria (CM) (n = 86), children with uncomplicated malaria (UM) (n = 81), and community children (CC) (n = 90). RESULTS: Serum VWF, sICAM-1, and sVCAM-1 levels were all elevated in asymptomatic community children with microscopy-confirmed parasitemia when compared with children without parasitemia by microscopy or polymerase chain reaction (all, P ≤ .05). Levels of VWF, sICAM-1, and sVCAM-1 were higher in children with UM than in CC (all, P < 0.001), but only VWF levels effectively distinguished CM from UM (P < 0.001), a finding confirmed by receiver operating characteristic analyses (area under the curve = 0.67; 95% confidence interval, .58-.75). Von Willebrand factor levels were lower in children with blood group O versus non-O blood groups across the disease spectrum, but VWF levels remained higher in CM versus UM, even after controlling for blood group. CONCLUSIONS: Endothelial activation, as assessed by serum levels of VWF, sICAM-1, and sVCAM-1, occurs even in subclinical P. falciparum parasitemia. Von Willebrand factor levels increase with greater malaria disease severity. Blood group O is associated with lower VWF levels, but presence of blood group O alone does not explain the higher VWF levels seen in children with CM. Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society 2012.
BACKGROUND: Endothelial activation may contribute to development of severe disease from Plasmodium falciparum infection, but optimal markers of endothelial activation in severe malaria, the extent of endothelial activation in asymptomatic infection, and the effect of blood group O on endothelial activation have not been defined. METHODS: Serum levels of 3 markers of endothelial activation-von Willebrand factor (VWF), soluble intercellular adhesion molecule-1 (sICAM-1), and soluble vascular cell adhesion molecule-1 (sVCAM-1)-were assessed in Ugandan children with cerebral malaria (CM) (n = 86), children with uncomplicated malaria (UM) (n = 81), and community children (CC) (n = 90). RESULTS: Serum VWF, sICAM-1, and sVCAM-1 levels were all elevated in asymptomatic community children with microscopy-confirmed parasitemia when compared with children without parasitemia by microscopy or polymerase chain reaction (all, P ≤ .05). Levels of VWF, sICAM-1, and sVCAM-1 were higher in children with UM than in CC (all, P < 0.001), but only VWF levels effectively distinguished CM from UM (P < 0.001), a finding confirmed by receiver operating characteristic analyses (area under the curve = 0.67; 95% confidence interval, .58-.75). Von Willebrand factor levels were lower in children with blood group O versus non-O blood groups across the disease spectrum, but VWF levels remained higher in CM versus UM, even after controlling for blood group. CONCLUSIONS: Endothelial activation, as assessed by serum levels of VWF, sICAM-1, and sVCAM-1, occurs even in subclinical P. falciparum parasitemia. Von Willebrand factor levels increase with greater malaria disease severity. Blood group O is associated with lower VWF levels, but presence of blood group O alone does not explain the higher VWF levels seen in children with CM. Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society 2012.
Authors: C Newbold; P Warn; G Black; A Berendt; A Craig; B Snow; M Msobo; N Peshu; K Marsh Journal: Am J Trop Med Hyg Date: 1997-10 Impact factor: 2.345
Authors: Quirijn de Mast; Evelyn Groot; Peter J Lenting; Philip G de Groot; Matthew McCall; Robert W Sauerwein; Rob Fijnheer; Andre van der Ven Journal: J Infect Dis Date: 2007-07-10 Impact factor: 5.226
Authors: Tamara D Clark; Denise Njama-Meya; Bridget Nzarubara; Catherine Maiteki-Sebuguzi; Bryan Greenhouse; Sarah G Staedke; Moses R Kamya; Grant Dorsey; Philip J Rosenthal Journal: PLoS One Date: 2010-07-30 Impact factor: 3.240
Authors: Happy T Phiri; Daniel J Bridges; Simon J Glover; Jan A van Mourik; Bas de Laat; Bridon M'baya; Terrie E Taylor; Karl B Seydel; Malcolm E Molyneux; E Brian Faragher; Alister G Craig; James E G Bunn Journal: PLoS One Date: 2011-11-17 Impact factor: 3.240
Authors: Andrew E Fry; Michael J Griffiths; Sarah Auburn; Mahamadou Diakite; Julian T Forton; Angela Green; Anna Richardson; Jonathan Wilson; Muminatou Jallow; Fatou Sisay-Joof; Margaret Pinder; Norbert Peshu; Thomas N Williams; Kevin Marsh; Malcolm E Molyneux; Terrie E Taylor; Kirk A Rockett; Dominic P Kwiatkowski Journal: Hum Mol Genet Date: 2007-11-13 Impact factor: 6.150
Authors: John Woodford; Tsin W Yeo; Kim A Piera; Kristy Butler; J Brice Weinberg; James S McCarthy; Nicholas M Anstey; Bridget E Barber Journal: Infect Immun Date: 2020-04-20 Impact factor: 3.441
Authors: Juliana N Anyanwu; Olatundun Williams; Casey L Sautter; Phillip Kasirye; Heather Hume; Robert O Opoka; Teresa Latham; Christopher Ndugwa; Russell E Ware; Chandy C John Journal: JMIR Res Protoc Date: 2016-06-23
Authors: Thao-Thy Pham; Chuchard Punsawad; Supattra Glaharn; Simon F De Meyer; Parnpen Viriyavejakul; Philippe E Van den Steen Journal: Malar J Date: 2019-12-03 Impact factor: 2.979
Authors: Augustina Frimpong; Jones Amponsah; Dorothy Agyemang; Abigail Sena Adjokatseh; Sophia Eyiah-Ampah; Nana Aba Ennuson; Dorotheah Obiri; Linda Eva Amoah; Kwadwo Asamoah Kusi Journal: Open Forum Infect Dis Date: 2021-06-04 Impact factor: 3.835